Top Bladder Cancer Therapeutics and Diagnostics Companies in North America

  1. Bristol-Myers Squibb Company

  2. AstraZeneca

  3. GlaxoSmithKline

  4. Johnson & Johnson

  5. Roche

*Disclaimer: Top companies sorted in no particular order

North America Bladder Cancer Therapeutics and Diagnostics Market Major Players

North America Bladder Cancer Therapeutics and Diagnostics - Competitive Concentration

North America Bladder Cancer Therapeutics and Diagnostics Market Concentration

List of Bladder Cancer Therapeutics and Diagnostics Companies in North America

  • AstraZeneca PLC

  • Bristol-Myers Squibb Company

  • Eli Lilly and Company

  • F. Hoffmann-La Roche Ltd

  • GlaxoSmithKline PLC

  • Novartis International AG

  • Pfizer Inc.

  • Sanofi SA

  • Johnson & Johnson (Janssen Pharmaceutical)

  • Abbott Laboratories

  • Cepheid

  • Pacific Edge Limited

Get more insights on North America Bladder Cancer Therapeutics and Diagnostics industry from our comprehensive report